Original language | English |
---|---|
Pages (from-to) | S123-S137 |
Journal | Diabetes Technology and Therapeutics |
Volume | 21 |
Issue number | S1 |
DOIs | |
State | Published - Feb 2019 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Diabetes Technology and Therapeutics, Vol. 21, No. S1, 02.2019, p. S123-S137.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Diabetes Technology and Therapy in the Pediatric Age Group
AU - Maahs, David M.
AU - Lal, Rayhan
AU - Shalitin, Shlomit
N1 - Funding Information: D.M.M. has research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust, and his institution has research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche. He has consulted for Abbott, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, and Insulet. Funding Information: R.L. is a Stephen Bechtel Endowed Adult and Pediatric Endocrinology Fellow through the Stanford Child Health Research Institute and is supported by a Diabetes, Endocrinology and Metabolism Training Grant (T32 DK007217) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Lal has consulted for Gly-Sens Incorporated and Abbott Diabetes Care. S.S. has no competing financial interests. Funding Information: D.M.M. has research support from the NIH, JDRF, NSF, and the Helmsley Charitable Trust, and his institution has research support from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Tandem, and Roche. He has consulted for Abbott, the Helmsley Charitable Trust, Sanofi, Novo Nordisk, Eli Lilly, and Insulet. R.L. is a Stephen Bechtel Endowed Adult and Pediatric Endocrinology Fellow through the Stanford Child Health Research Institute and is supported by a Diabetes, Endocrinology and Metabolism Training Grant (T32 DK007217) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr. Lal has consulted for Gly- Sens Incorporated and Abbott Diabetes Care.
PY - 2019/2
Y1 - 2019/2
UR - http://www.scopus.com/inward/record.url?scp=85061860618&partnerID=8YFLogxK
U2 - 10.1089/dia.2019.2510
DO - 10.1089/dia.2019.2510
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30785328
AN - SCOPUS:85061860618
SN - 1520-9156
VL - 21
SP - S123-S137
JO - Diabetes Technology and Therapeutics
JF - Diabetes Technology and Therapeutics
IS - S1
ER -